Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

about

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

Item

http://www.wikidata.org/entity/Q47640245

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@en

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@nl

type

Item

label

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@en

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@nl

prefLabel

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@en

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@nl

P1476

Rare upper gastrointestinal hemorrhage of cetuximab: A case report.

@en

P2093

Bao-Cheng Gong

http://www.w3.org/2001/XMLSchema#string

Fu-Nan Liu

http://www.w3.org/2001/XMLSchema#string

Han-Wei Huang

http://www.w3.org/2001/XMLSchema#string

Hui-Mian Xu

http://www.w3.org/2001/XMLSchema#string

Lei Luo

http://www.w3.org/2001/XMLSchema#string

Peng-Liang Wang

http://www.w3.org/2001/XMLSchema#string

Shi-Jie Duan

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Ya-Nan Xing

http://www.w3.org/2001/XMLSchema#string

Zi-Ming Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Risk assessment after acute upper gastrointestinal haemorrhage.

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review.

Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting.

Epidermal growth factor receptor biology (IMC-C225).

Review: side effects of approved molecular targeted therapies in solid cancers.

Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy

Why the epidermal growth factor receptor? The rationale for cancer therapy.

P304

e9391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1097/MD.0000000000009391

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29390545

http://www.w3.org/2001/XMLSchema#string

P921

cetuximab

P932

5758247

http://www.w3.org/2001/XMLSchema#string